Scott Rosen

Scott is a Partner at Transformation Capital, which is the largest investment firm focused exclusively on digital health, typically making growth stage investments of $15 – 60m. He serves in a Board capacity at CapitalRx, Datavant, SWORD, Longevity Health, Annexus, Arbital, CertifyOS and Local Infusion. 

Prior to joining Transformation, Scott led Strategy and M&A at eviCore, a provider of specialty benefit value-based care solutions that was sold to Express Scripts. Previously, he was an investor with Court Square Capital and investment banker at Evercore. Scott graduated from the University of Virginia with an B.S. from the McIntire School of Commerce with Distinction.